“…PMDD women also report more traumatic life stress, including sexual and physical abuse histories (Paddison et al, 1990;Golding & Taylor, 1996Girdler et al, 2003Girdler et al, , 2007. Since allopregnanolone is stress responsive, at least in animal models (Purdy et al, 1991;Barbaccia et al, 1996Barbaccia et al, , 1997, greater allostatic load in PMDD resulting from more severe life stress could contribute to the elevated allopregnanolone concentrations that we have seen in PMDD women (Girdler et al, 2001) and result in the documented alterations in GABA A receptor function in PMDD (Sundstrom et al, 1997a(Sundstrom et al, , 1997b(Sundstrom et al, , 1998, including alterations in the agonism properties of the GABA A receptor as animal models (Smith et al, 2006) and human studies of PMDD suggest (Le Melledo et al, 2000). This could then explain the seemingly paradoxical association between increasing allopregnanolone concentrations in the luteal phase and increased dysphoric mood states in PMDD.…”